11-124382485-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001005468.2(OR8B2):c.859C>T(p.Leu287Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,613,924 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005468.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR8B2 | NM_001005468.2 | c.859C>T | p.Leu287Phe | missense_variant | 2/2 | ENST00000641451.2 | |
OR8B2 | XM_017017535.3 | c.859C>T | p.Leu287Phe | missense_variant | 3/3 | ||
OR8B2 | XM_017017536.2 | c.859C>T | p.Leu287Phe | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR8B2 | ENST00000641451.2 | c.859C>T | p.Leu287Phe | missense_variant | 2/2 | NM_001005468.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152162Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251008Hom.: 1 AF XY: 0.0000221 AC XY: 3AN XY: 135656
GnomAD4 exome AF: 0.0000280 AC: 41AN: 1461762Hom.: 0 Cov.: 31 AF XY: 0.0000275 AC XY: 20AN XY: 727176
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152162Hom.: 1 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 31, 2023 | The c.859C>T (p.L287F) alteration is located in exon 1 (coding exon 1) of the OR8B2 gene. This alteration results from a C to T substitution at nucleotide position 859, causing the leucine (L) at amino acid position 287 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at